Literature DB >> 21641938

Chlordiazepoxide and lavender oil alter unconditioned anxiety-induced c-fos expression in the rat brain.

D Shaw1, K Norwood, J C Leslie.   

Abstract

Lavender oil has a long history of use for treating anxiety, but only recent research has examined its effects using standard behavioural methods used to test novel drugs. The aim of this study was to investigate the effects of inhaled lavender oil on anxiety related behaviour of rats in the open field and to compare them with the effects of chlordiazepoxide (CDP), a typical anxiolytic drug. Additionally c-fos immunochemistry was used to investigate whether lavender oil produced the same pattern of c-fos expression as CDP in eight different brain areas associated with anxiety. As previously found, lavender oil showed anxiolytic properties in the open field similar to but not as extensive as those of CDP. Immunochemistry results indicated that exposure to the open field increased c-fos expression, while CDP reversed the effects of this behavioural stressor on c-fos expression in all brain regions examined except the central nucleus of the amygdala, where c-fos expression increased. Lavender oil had similar effects to CDP on the paraventricular nucleus of the hypothalamus, the dorsomedial hypothalamic nucleus and the central nucleus of the amygdala. These results strengthen the suggestion that inhaling lavender oil has anxiolytic behavioural effects, but they are weaker than the effects of benzodiazepines, and there is limited evidence that they are mediated by the same neural processes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641938     DOI: 10.1016/j.bbr.2011.05.014

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  8 in total

1.  The involvement of 5-lipoxygenase activating protein in anxiety-like behavior.

Authors:  Yash B Joshi; Domenico Praticò
Journal:  J Psychiatr Res       Date:  2013-01-26       Impact factor: 4.791

2.  Randomized controlled trial for Salvia sclarea or Lavandula angustifolia: differential effects on blood pressure in female patients with urinary incontinence undergoing urodynamic examination.

Authors:  Geun Hee Seol; Yun Hee Lee; Purum Kang; Ji Hye You; Mira Park; Sun Seek Min
Journal:  J Altern Complement Med       Date:  2013-01-29       Impact factor: 2.579

3.  Amphetamine Withdrawal Differentially Increases the Expression of Organic Cation Transporter 3 and Serotonin Transporter in Limbic Brain Regions.

Authors:  Rajeshwari R Solanki; Jamie L Scholl; Michael J Watt; Kenneth J Renner; Gina L Forster
Journal:  J Exp Neurosci       Date:  2016-07-21

4.  Lavandula angustifolia Mill. Oil and Its Active Constituent Linalyl Acetate Alleviate Pain and Urinary Residual Sense after Colorectal Cancer Surgery: A Randomised Controlled Trial.

Authors:  So Hyun Yu; Geun Hee Seol
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-05       Impact factor: 2.629

5.  Anxiolytic Activity and Brain Modulation Pattern of the α-Casozepine-Derived Pentapeptide YLGYL in Mice.

Authors:  Simon Benoit; Catherine Chaumontet; Jessica Schwarz; Céline Cakir-Kiefer; Audrey Boulier; Daniel Tomé; Laurent Miclo
Journal:  Nutrients       Date:  2020-05-21       Impact factor: 5.717

6.  IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis.

Authors:  Fan Zhang; Renee Drabier
Journal:  BMC Bioinformatics       Date:  2012-09-11       Impact factor: 3.169

7.  Modification of sleep-waking and electroencephalogram induced by vetiver essential oil inhalation.

Authors:  Dania Cheaha; Acharaporn Issuriya; Rodiya Manor; Jackapun Kwangjai; Thitima Rujiralai; Ekkasit Kumarnsit
Journal:  J Intercult Ethnopharmacol       Date:  2016-02-14

8.  Lavender Oil Reduces Depressive Mood in Healthy Individuals and Enhances the Activity of Single Oxytocin Neurons of the Hypothalamus Isolated from Mice: A Preliminary Study.

Authors:  Keizaburo Ogata; Koji Ataka; Hajime Suzuki; Takakazu Yagi; Ayumi Okawa; Takamasa Fukumoto; Boyang Zhang; Masanori Nakata; Toshihiko Yada; Akihiro Asakawa
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-14       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.